Chromosome 20p11.2 deletions cause congenital hyperinsulinism via the loss of FOXA2 or its regulatory elements
Article in European Journal of Human Genetics (April 2024)
The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.
Untargeted metabolomic, and proteomic analysis identifies metabolic biomarkers and pathway alterations in individuals with 22q11.2 deletion syndrome
Article in Metabolomics (January 2024)
Investigation of 22q11.2 Deletion in Japanese Early‐Onset Parkinsonism
Article in Movement Disorders (December 2023)